Cargando…
The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review
BACKGROUND: Rare diseases negatively impact patients’ quality of life, but the estimation of health state utility values (HSUVs) in research studies and cost–utility models for health technology assessment is challenging. OBJECTIVES: This study compared the methods for estimating the HSUVs included...
Autores principales: | Meregaglia, Michela, Nicod, Elena, Drummond, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406664/ https://www.ncbi.nlm.nih.gov/pubmed/36335234 http://dx.doi.org/10.1007/s10198-022-01541-y |
Ejemplares similares
-
A qualitative study of manufacturers' submissions to the UK NICE single technology appraisal process
por: Kaltenthaler, Eva C, et al.
Publicado: (2012) -
The NICE Medical Technologies Evaluation Programme (MTEP): manufacturer submission challenges
por: Sprange, Kirsty, et al.
Publicado: (2012) -
The impact of rarity in NICE’s health technology appraisals
por: Clarke, Sophie, et al.
Publicado: (2021) -
Decision making in NICE single technological appraisals: How does NICE incorporate patient perspectives?
por: Hashem, Ferhana, et al.
Publicado: (2017) -
Biologic agents for rheumatoid arthritis—negotiating the NICE technology appraisals
por: Kiely, Patrick D. W., et al.
Publicado: (2012)